These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 21451498)

  • 1. Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naïve boys with attention-deficit hyperactivity disorder.
    Rubia K; Halari R; Cubillo A; Smith AB; Mohammad AM; Brammer M; Taylor E
    Neuropsychopharmacology; 2011 Jul; 36(8):1575-86. PubMed ID: 21451498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.
    Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Psychol Med; 2014 Feb; 44(3):633-46. PubMed ID: 23597077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder.
    Rubia K; Halari R; Mohammad AM; Taylor E; Brammer M
    Biol Psychiatry; 2011 Aug; 70(3):255-62. PubMed ID: 21664605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents.
    Kowalczyk OS; Cubillo AI; Smith A; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Eur Neuropsychopharmacol; 2019 Oct; 29(10):1102-1116. PubMed ID: 31358436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.
    Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer MJ; Simmons A; Rubia K
    Cereb Cortex; 2014 Jan; 24(1):174-85. PubMed ID: 23048018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.
    Smith A; Cubillo A; Barrett N; Giampietro V; Simmons A; Brammer M; Rubia K
    Biol Psychiatry; 2013 Oct; 74(8):615-22. PubMed ID: 23731741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared and disorder-specific prefrontal abnormalities in boys with pure attention-deficit/hyperactivity disorder compared to boys with pure CD during interference inhibition and attention allocation.
    Rubia K; Halari R; Smith AB; Mohammad M; Scott S; Brammer MJ
    J Child Psychol Psychiatry; 2009 Jun; 50(6):669-78. PubMed ID: 19236528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate normalizes resting-state brain dysfunction in boys with attention deficit hyperactivity disorder.
    An L; Cao XH; Cao QJ; Sun L; Yang L; Zou QH; Katya R; Zang YF; Wang YF
    Neuropsychopharmacology; 2013 Jun; 38(7):1287-95. PubMed ID: 23340519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fronto-striatal underactivation during interference inhibition and attention allocation in grown up children with attention deficit/hyperactivity disorder and persistent symptoms.
    Cubillo A; Halari R; Giampietro V; Taylor E; Rubia K
    Psychiatry Res; 2011 Jul; 193(1):17-27. PubMed ID: 21601434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose effects of methylphenidate and atomoxetine on functional connectivity during an n-back task in boys with ADHD.
    Kowalczyk OS; Cubillo AI; Criaud M; Giampietro V; O'Daly OG; Mehta MA; Rubia K
    Psychopharmacology (Berl); 2023 Oct; 240(10):2045-2060. PubMed ID: 37500785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.
    del Campo N; Fryer TD; Hong YT; Smith R; Brichard L; Acosta-Cabronero J; Chamberlain SR; Tait R; Izquierdo D; Regenthal R; Dowson J; Suckling J; Baron JC; Aigbirhio FI; Robbins TW; Sahakian BJ; Müller U
    Brain; 2013 Nov; 136(Pt 11):3252-70. PubMed ID: 24163364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder.
    Prehn-Kristensen A; Krauel K; Hinrichs H; Fischer J; Malecki U; Schuetze H; Wolff S; Jansen O; Duezel E; Baving L
    Brain Res; 2011 May; 1388():56-68. PubMed ID: 21385569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse fluoxetine effects on inhibitory brain activation in non-comorbid boys with ADHD and with ASD.
    Chantiluke K; Barrett N; Giampietro V; Santosh P; Brammer M; Simmons A; Murphy DG; Rubia K
    Psychopharmacology (Berl); 2015 Jun; 232(12):2071-82. PubMed ID: 25533997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of acute fluoxetine administration on temporal discounting in youth with ADHD.
    Carlisi CO; Chantiluke K; Norman L; Christakou A; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Psychol Med; 2016 Apr; 46(6):1197-209. PubMed ID: 26708124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.
    Hart H; Radua J; Nakao T; Mataix-Cols D; Rubia K
    JAMA Psychiatry; 2013 Feb; 70(2):185-98. PubMed ID: 23247506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-Dose Methylphenidate-Induced Changes in Brain Functional Connectivity Are Correlated With 3-Month Attention-Deficit/Hyperactivity Disorder Symptom Response.
    Silberstein RB; Levy F; Pipingas A; Farrow M
    Biol Psychiatry; 2017 Nov; 82(9):679-686. PubMed ID: 28465019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disorder-specific dysfunctions in patients with attention-deficit/hyperactivity disorder compared to patients with obsessive-compulsive disorder during interference inhibition and attention allocation.
    Rubia K; Cubillo A; Woolley J; Brammer MJ; Smith A
    Hum Brain Mapp; 2011 Apr; 32(4):601-11. PubMed ID: 21391250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verbal working memory-related functional connectivity alterations in boys with attention-deficit/hyperactivity disorder and the effects of methylphenidate.
    Wu ZM; Bralten J; An L; Cao QJ; Cao XH; Sun L; Liu L; Yang L; Mennes M; Zang YF; Franke B; Hoogman M; Wang YF
    J Psychopharmacol; 2017 Aug; 31(8):1061-1069. PubMed ID: 28656805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disorder-specific inferior prefrontal hypofunction in boys with pure attention-deficit/hyperactivity disorder compared to boys with pure conduct disorder during cognitive flexibility.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Scott S; Brammer M
    Hum Brain Mapp; 2010 Dec; 31(12):1823-33. PubMed ID: 20205245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.